Building Australia through Innovation
Join us at the second Bionics Institute Innovation Lecture on Wednesday 17 May 2023 at 5.45pm
After the success of the inaugural event, the 2023 Innovation Lecture will be invitation-only.
The focus of this year’s event is to bring med tech leaders together to explore how Australia can accurately measure innovation, boost the med tech ecosystem and strengthen connections.
Networking drinks following the lecture will provide guests with the opportunity to forge partnerships and develop links with like-minded people.
Register your interest in receiving an invitation to attend this free event and hear from our industry panel and keynote speakers:
Date: Wednesday 17 May 2023
Time: 5.15pm arrival for 5.45pm start
Networking drinks: 7.45 – 9.30pm
Venue: RACV City Club, 501 Bourke St, Melbourne
Cost: Attendance is free
RSVP: Register your interest in receiving an invitation
Who is attending?
Through the Innovation Lecture series, the Bionics Institute aims to develop a shared understanding of what it will take to build Australia through innovation between:
– Med tech thought leaders
– Start-up founders and entrepreneurs
– Government agencies and peak bodies
– Impact investors, fund managers and VCs
– Healthcare and tertiary education leaders
– Trusts, foundations and philanthropists
– Business media.
Position your brand as an innovation leader and forge wide-reaching connections across the med tech ecosystem.
Talk to our team about the range of brand acknowledgement, promotional and hospitality benefits available to sponsors in 2023 by emailing: firstname.lastname@example.org
Keynote speaker: Dr Andreas Fouras, CEO of 4DMedical
4DMedical was incorporated in 2012 to acquire the imaging platform XV Technology from Monash University, where it was originally conceived and developed by Andreas and his former research group.
4DMedical aims to change the outcome for patients with lung disease by revolutionising respiratory and ventilation analysis using this technology, which is the first FDA approved respiratory imaging system using algorithms to convert x-ray image sequences into four-dimensional data to enhance clinical management.
In May 2020, 4DMedical obtained FDA approval for its XV technology and in August 2020 completed an initial public offering (IPO) on the ASX, raising $56 million. The global market for respiratory diagnostics is currently estimated to exceed $US30 billion per annum.
After completing his PhD in engineering, Andreas rose to the position of Professor of Mechanical and Aerospace Engineering and Director of the Laboratory for Dynamic Imaging at Monash University. Andreas is now the founding CEO of 4DMedical, based in Melbourne and Los Angeles.
Keynote speaker: Dr Kylie Walker, CEO of ATSE
Kylie is the CEO of the Australian Academy of Technology and Engineering (ATSE), where she works with expert Fellows to lead crucial national conversations and strategy towards a thriving, healthy and connected Australia supported by technology.
Kylie specialises in connecting technologists, engineers and scientists with governments, business, media and society – skills built over many years in senior federal communication and advocacy roles in the science, technology and health sectors.
As the immediate past CEO of Science & Technology Australia, Kylie led campaigns to increase investment in Australian research and development, and created the acclaimed Superstars of STEM program, championing Australian women in science technology, engineering and mathematics.
Kylie is also a visiting Fellow at the Australian Centre for the Public Awareness of Science. She was Chair of the Australian National Commission for UNESCO and in 2019, she was named in the 100 Women of Influence list by the Australian Financial Review for her work on improving equity, diversity and inclusion in STEM.